Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CAPECITABINE vs CAPMATINIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

CAPECITABINE vs CAPMATINIB: Safety Overview

Metric CAPECITABINE CAPMATINIB
Total FAERS Reports 63,506 2,301
Deaths Reported 8,892 583
Death Rate 14.0% 25.3%
Hospitalizations 17,529 388
Average Patient Age 61.8 yrs 71.9 yrs
% Female Patients 65.1% 53.9%
FDA Approval Date Apr 17, 2018 May 6, 2020
Manufacturer Aurobindo Pharma Limited Novartis Pharmaceuticals Corporation
Route ORAL ORAL
Marketing Status Discontinued Prescription